Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 (BraCE-DM2)
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 (BraCE-DM2)
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Listed as NCT05854433, this observational or N/A phase trial focuses on Myotonic Dystrophy Type 1 and Myotonic Dystrophy Type 2 and remains actively recruiting participants. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Aug 2025 — Feb 2026 [monthly]
Recruiting
-
Mar 2025 — Aug 2025 [monthly]
Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
-
Apr 2024 — Jun 2024 [monthly]
Recruiting
-
Jun 2023 — Apr 2024 [monthly]
Recruiting
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .